Search research articles
Contact Us
Filters
Showing results (181-190 of 209) with videos related to
Page
of 21
Sort By:
Applied Neuropsychology. Child
|
February 17, 2024
RETRACTED ARTICLE: Psychological Resilience, Emotional Symptoms, and Recovery Duration in Adolescent Sport-Related Concussion
Julia C Nahman, Cody Staples, Lauren N Irwin Harper, et al.
Psychological Assessment
|
June 2, 2020
Rethinking hyperactivity in pediatric ADHD: Preliminary evidence for a reconceptualization of hyperactivity/impulsivity from the perspective of informant perceptual processes
Michael J Kofler, Nicole B Groves, Leah J Singh, et al.
Journal of the American Pharmacists Association : Japha
|
April 6, 2021
Examining nonprescription syringe sales in Massachusetts and Rhode Island community pharmacies
Traci C Green, Thomas Stopka, Ziming Xuan, et al.
Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence
|
January 18, 2021
Activities of daily living and working memory in pediatric attention-deficit/hyperactivity disorder (ADHD)
Lauren N Irwin, Elia F Soto, Elizabeth S M Chan, et al.
Journal of the American Pharmacists Association : Japha
|
October 20, 2023
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains
Traci C Green, Joseph Silcox, Derek Bolivar, et al.
Research in Social & Administrative Pharmacy : RSAP
|
February 23, 2024
"I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials
Adriane N Irwin, Mary Gray, Daniel Ventricelli, et al.
Diabetes, Obesity & Metabolism
|
May 2, 2015
Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide
S Patterson, M de Kort, N Irwin, et al.
The Journal of Endocrinology
|
March 12, 2004
N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity
B D Green, M H Mooney, V A Gault, et al.
The Journal of Endocrinology
|
October 27, 2006
Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice
J C Parker, K S Lavery, N Irwin, et al.
Metabolism: Clinical and Experimental
|
February 10, 2004
Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39)
B D Green, M H Mooney, V A Gault, et al.
Page
of 21
Search research articles
Search
Showing results (181-190 of 209) with videos related to
Sort By:
Page
of 21
Applied Neuropsychology. Child
|
February 17, 2024
RETRACTED ARTICLE: Psychological Resilience, Emotional Symptoms, and Recovery Duration in Adolescent Sport-Related Concussion
Julia C Nahman, Cody Staples, Lauren N Irwin Harper, et al.
Psychological Assessment
|
June 2, 2020
Rethinking hyperactivity in pediatric ADHD: Preliminary evidence for a reconceptualization of hyperactivity/impulsivity from the perspective of informant perceptual processes
Michael J Kofler, Nicole B Groves, Leah J Singh, et al.
Journal of the American Pharmacists Association : Japha
|
April 6, 2021
Examining nonprescription syringe sales in Massachusetts and Rhode Island community pharmacies
Traci C Green, Thomas Stopka, Ziming Xuan, et al.
Child Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence
|
January 18, 2021
Activities of daily living and working memory in pediatric attention-deficit/hyperactivity disorder (ADHD)
Lauren N Irwin, Elia F Soto, Elizabeth S M Chan, et al.
Journal of the American Pharmacists Association : Japha
|
October 20, 2023
Pharmacy staff-reported adaptations to naloxone provision and over-the-counter (OTC) syringe sales during the COVID-19 pandemic: Experiences across multiple states and 2 pharmacy chains
Traci C Green, Joseph Silcox, Derek Bolivar, et al.
Research in Social & Administrative Pharmacy : RSAP
|
February 23, 2024
"I go out of my way to give them an extra smile now:" A study of pharmacists who participated in Respond to Prevent, a community pharmacy intervention to accelerate provision of harm reduction materials
Adriane N Irwin, Mary Gray, Daniel Ventricelli, et al.
Diabetes, Obesity & Metabolism
|
May 2, 2015
Pharmacological characterization and antidiabetic activity of a long-acting glucagon-like peptide-1 analogue conjugated to an antithrombin III-binding pentasaccharide
S Patterson, M de Kort, N Irwin, et al.
The Journal of Endocrinology
|
March 12, 2004
N-terminal His(7)-modification of glucagon-like peptide-1(7-36) amide generates dipeptidyl peptidase IV-stable analogues with potent antihyperglycaemic activity
B D Green, M H Mooney, V A Gault, et al.
The Journal of Endocrinology
|
October 27, 2006
Effects of sub-chronic exposure to naturally occurring N-terminally truncated metabolites of glucose-dependent insulinotrophic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1), GIP(3-42) and GLP-1(9-36)amide, on insulin secretion and glucose homeostasis in ob/ob mice
J C Parker, K S Lavery, N Irwin, et al.
Metabolism: Clinical and Experimental
|
February 10, 2004
Lys9 for Glu9 substitution in glucagon-like peptide-1(7-36)amide confers dipeptidylpeptidase IV resistance with cellular and metabolic actions similar to those of established antagonists glucagon-like peptide-1(9-36)amide and exendin (9-39)
B D Green, M H Mooney, V A Gault, et al.
Page
of 21